FT895

CAS No. 2225728-57-2

FT895( FT 895 | FT-895 )

Catalog No. M13554 CAS No. 2225728-57-2

FT895 (FT-895) is a potent and selective inhibitor of HDAC11 with IC50 of 3 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 255 In Stock
5MG 231 In Stock
10MG 358 In Stock
25MG 601 In Stock
50MG 821 In Stock
100MG 1144 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    FT895
  • Note
    Research use only, not for human use.
  • Brief Description
    FT895 (FT-895) is a potent and selective inhibitor of HDAC11 with IC50 of 3 nM.
  • Description
    FT895 (FT-895) is a potent and selective inhibitor of HDAC11 with IC50 of 3 nM, displays no significant activity against HDAC1-10 (IC50>5 uM); displays promising cellular activity (IC50<20 nM) and pharmacokinetic properties; FT895 is a useful tool to study the biology of HDAC11 and shows potential use as a therapeutic target for oncology and inflammation indications.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    FT 895 | FT-895
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2225728-57-2
  • Formula Weight
    352.317
  • Molecular Formula
    C16H15F3N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (354.80 mM)
  • SMILES
    O=C(NO)C1=C(CN(C2=CN=C(C(F)(F)F)C=N2)C3(C)C)C3=CC=C1
  • Chemical Name
    N-hydroxy-1,1-dimethyl-2-(5-(trifluoromethyl)pyrazin-2-yl)isoindoline-4-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Martin MW, et al. Bioorg Med Chem Lett. 2018 Jul 1;28(12):2143-2147.
molnova catalog
related products
  • HDACi-4b

    A benzamide-type HDAC inhibitor with IC50 of 78 uM for changes of FXN mRNA in affected GM15850 cells.

  • RGFP 966

    RGFP966 is an HDAC3 inhibitor with IC50 of 0.08 μM in cell-free assay, exhibits > 200-fold selectivity over other HDAC.

  • Remetinostat

    Remetinostat is a hydroxamic acid-based inhibitor of histone deacetylase enzymes.